Scaf­folds for Drug Deliv­ery and Tis­sue Regeneration


for Sus­tained and Con­trol­lable Drug Release and Tis­sue Regeneration

scaffolds 03

Drug Deliv­ery Nanoplatforms:

  • Con­trol­lable and sus­tained release of drugs
  • Encap­su­la­tion of mul­ti­ple nanocarriers
  • Con­trol­lable biodegra­da­tion ratio through the body
  • Con­stant release of anti-​inflammatory, anti-​restenotic, anti-​thrombotic Drugs to over­come Stent complications
  • Sus­tained Release of anti-​inflammatory drugs or antibiotics
  • Tar­geted Drug Deliv­ery at the dis­eased site
Biodegrad­able Scaf­folds onto Implants

Nanofi­brous nanoplat­forms to be used coat­ings onto implants via Elec­tro­spin­ning Deposition

implants 01

implants 02

Car­dio­vas­cu­lar Implants (stents, car­diac valves)

  • Release of anti-​inflammatory, anti-​oxidant and antiplatelet drugs
  • Pro­mote implant endothelialization

Ortho­pe­dic Implants

  • Release of anti-​inflammatory and antibi­otic drugs
  • Pro­mote implant inte­gra­tion with sur­round­ing tissues
  • Inhi­bi­tion of implant infection
Scaf­folds for Tis­sue Regeneration
  • Elec­tro­spin­ning Sys­tem Deposition
  • Bio­func­tion­al­iza­tion
  • Physic­o­chem­i­cal and Bio­log­i­cal Characterization
  • In vitro regen­er­a­tion of bone, car­ti­lage, skin, car­diac tissues

scaffolds 01

(a) SEM and (b) AFM images of Elec­tro­spun
nanoscaf­folds for tis­sue regeneration

scaffolds 02
All rights reserved. Copy­righted by BL Nanobio­med 20142022.
Joomla tem­plates by Joomlashine

This website uses cookies to ensure you get the best experience on our website. Privacy Policy